255 related articles for article (PubMed ID: 15728611)
1. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer.
Yeh E; Slanetz P; Kopans DB; Rafferty E; Georgian-Smith D; Moy L; Halpern E; Moore R; Kuter I; Taghian A
AJR Am J Roentgenol; 2005 Mar; 184(3):868-77. PubMed ID: 15728611
[TBL] [Abstract][Full Text] [Related]
2. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
[TBL] [Abstract][Full Text] [Related]
3. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy.
Londero V; Bazzocchi M; Del Frate C; Puglisi F; Di Loreto C; Francescutti G; Zuiani C
Eur Radiol; 2004 Aug; 14(8):1371-9. PubMed ID: 14986052
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging.
Abraham DC; Jones RC; Jones SE; Cheek JH; Peters GN; Knox SM; Grant MD; Hampe DW; Savino DA; Harms SE
Cancer; 1996 Jul; 78(1):91-100. PubMed ID: 8646731
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy.
Shin HJ; Kim HH; Ahn JH; Kim SB; Jung KH; Gong G; Son BH; Ahn SH
Br J Radiol; 2011 Jul; 84(1003):612-20. PubMed ID: 21081579
[TBL] [Abstract][Full Text] [Related]
6. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy.
Schott AF; Roubidoux MA; Helvie MA; Hayes DF; Kleer CG; Newman LA; Pierce LJ; Griffith KA; Murray S; Hunt KA; Paramagul C; Baker LH
Breast Cancer Res Treat; 2005 Aug; 92(3):231-8. PubMed ID: 16155794
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
Peintinger F; Kuerer HM; Anderson K; Boughey JC; Meric-Bernstam F; Singletary SE; Hunt KK; Whitman GJ; Stephens T; Buzdar AU; Green MC; Symmans WF
Ann Surg Oncol; 2006 Nov; 13(11):1443-9. PubMed ID: 17028770
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
Chagpar AB; Middleton LP; Sahin AA; Dempsey P; Buzdar AU; Mirza AN; Ames FC; Babiera GV; Feig BW; Hunt KK; Kuerer HM; Meric-Bernstam F; Ross MI; Singletary SE
Ann Surg; 2006 Feb; 243(2):257-64. PubMed ID: 16432360
[TBL] [Abstract][Full Text] [Related]
9. Comparative accuracy of preoperative tumor size assessment on mammography, sonography, and MRI: Is the accuracy affected by breast density or cancer subtype?
Leddy R; Irshad A; Metcalfe A; Mabalam P; Abid A; Ackerman S; Lewis M
J Clin Ultrasound; 2016 Jan; 44(1):17-25. PubMed ID: 26294391
[TBL] [Abstract][Full Text] [Related]
10. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
Scheel JR; Kim E; Partridge SC; Lehman CD; Rosen MA; Bernreuter WK; Pisano ED; Marques HS; Morris EA; Weatherall PT; Polin SM; Newstead GM; Esserman LJ; Schnall MD; Hylton NM;
AJR Am J Roentgenol; 2018 Jun; 210(6):1376-1385. PubMed ID: 29708782
[TBL] [Abstract][Full Text] [Related]
11. Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?
Wright FC; Zubovits J; Gardner S; Fitzgerald B; Clemons M; Quan ML; Causer P
J Surg Oncol; 2010 Jun; 101(7):604-10. PubMed ID: 20461768
[TBL] [Abstract][Full Text] [Related]
12. Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?
Segara D; Krop IE; Garber JE; Winer E; Harris L; Bellon JR; Birdwell R; Lester S; Lipsitz S; Iglehart JD; Golshan M
J Surg Oncol; 2007 Nov; 96(6):474-80. PubMed ID: 17640031
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
[TBL] [Abstract][Full Text] [Related]
14. Preoperative clinical, mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancer.
Sperber F; Weinstein Y; Sarid D; Ben Yosef R; Shalmon A; Yaal-Hahoshen N
Isr Med Assoc J; 2006 May; 8(5):342-6. PubMed ID: 16805235
[TBL] [Abstract][Full Text] [Related]
15. Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy.
Park J; Chae EY; Cha JH; Shin HJ; Choi WJ; Choi YW; Kim HH
Eur J Radiol; 2018 Nov; 108():261-268. PubMed ID: 30396666
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
Marinovich ML; Houssami N; Macaskill P; Sardanelli F; Irwig L; Mamounas EP; von Minckwitz G; Brennan ME; Ciatto S
J Natl Cancer Inst; 2013 Mar; 105(5):321-33. PubMed ID: 23297042
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.
Croshaw R; Shapiro-Wright H; Svensson E; Erb K; Julian T
Ann Surg Oncol; 2011 Oct; 18(11):3160-3. PubMed ID: 21947594
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI.
Kim HJ; Im YH; Han BK; Choi N; Lee J; Kim JH; Choi YL; Ahn JS; Nam SJ; Park YS; Choe YH; Ko YH; Yang JH
Acta Oncol; 2007; 46(7):996-1003. PubMed ID: 17851879
[TBL] [Abstract][Full Text] [Related]
19. Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
Um E; Kang JW; Lee S; Kim HJ; Yoon TI; Sohn G; Chung IY; Kim J; Lee JW; Son BH; Ahn SH; Ko BS
Clin Breast Cancer; 2018 Oct; 18(5):e1087-e1091. PubMed ID: 29703689
[TBL] [Abstract][Full Text] [Related]
20. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI.
Balu-Maestro C; Chapellier C; Bleuse A; Chanalet I; Chauvel C; Largillier R
Breast Cancer Res Treat; 2002 Mar; 72(2):145-52. PubMed ID: 12038705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
